XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Beginning Balances at Dec. 31, 2023 $ 48,246,027 $ 111,535 $ 49,229,020 $ (1,094,528)
Beginning Balance, shares at Dec. 31, 2023   11,153,513    
Restricted stock grants issued   $ 1,144 (1,144)  
Restricted stock grants issued, Shares   114,378    
Restricted stock grants forfeiture   $ (8) 8  
Restricted stock grants forfeitures, shares   (843)    
Stock-based compensation 71,004   71,004  
Net income 266,150     266,150
Dividends (808,568)     (808,568)
Ending Balance at Mar. 31, 2024 47,774,613 $ 112,671 49,298,888 (1,636,946)
Ending Balance, shares at Mar. 31, 2024   11,267,048    
Beginning Balances at Dec. 31, 2023 48,246,027 $ 111,535 49,229,020 (1,094,528)
Beginning Balance, shares at Dec. 31, 2023   11,153,513    
Net income 2,039,337      
Ending Balance at Sep. 30, 2024 48,061,216 $ 112,673 49,446,018 (1,497,475)
Ending Balance, shares at Sep. 30, 2024   11,267,253    
Beginning Balances at Mar. 31, 2024 47,774,613 $ 112,671 49,298,888 (1,636,946)
Beginning Balance, shares at Mar. 31, 2024   11,267,048    
Restricted stock grants issued   $ 4 (4)  
Restricted stock grants issued, Shares   400    
Restricted stock grants forfeiture   $ (7) 7  
Restricted stock grants forfeitures, shares   (687)    
Stock-based compensation 72,925   72,925  
Net income 591,530     591,530
Dividends (816,841)     (816,841)
Ending Balance at Jun. 30, 2024 47,622,227 $ 112,668 49,371,816 (1,862,257)
Ending Balance, shares at Jun. 30, 2024   11,266,761    
Restricted stock grants issued   $ 5 (5)  
Restricted stock grants issued, Shares   492    
Stock-based compensation 74,207   74,207  
Net income 1,181,657     1,181,657
Dividends (816,875)     (816,875)
Ending Balance at Sep. 30, 2024 48,061,216 $ 112,673 49,446,018 (1,497,475)
Ending Balance, shares at Sep. 30, 2024   11,267,253    
Beginning Balances at Dec. 31, 2024 $ 47,437,677 $ 112,927 49,559,986 (2,235,236)
Beginning Balance, shares at Dec. 31, 2024 11,292,772 11,292,772    
Restricted stock grants issued   $ 460 (460)  
Restricted stock grants issued, Shares   45,994    
Restricted stock grants forfeiture   $ (3) 3  
Restricted stock grants forfeitures, shares   (375)    
Stock-based compensation $ 100,736   100,736  
Net income 555,152     555,152
Dividends (818,726)     (818,726)
Ending Balance at Mar. 31, 2025 47,274,839 $ 113,384 49,660,265 (2,498,810)
Ending Balance, shares at Mar. 31, 2025   11,338,391    
Beginning Balances at Dec. 31, 2024 $ 47,437,677 $ 112,927 49,559,986 (2,235,236)
Beginning Balance, shares at Dec. 31, 2024 11,292,772 11,292,772    
Net income $ 1,715,627      
Ending Balance at Sep. 30, 2025 $ 46,934,486 $ 113,377 49,803,438 (2,982,329)
Ending Balance, shares at Sep. 30, 2025 11,337,720 11,337,720    
Beginning Balances at Mar. 31, 2025 $ 47,274,839 $ 113,384 49,660,265 (2,498,810)
Beginning Balance, shares at Mar. 31, 2025   11,338,391    
Restricted stock grants issued   $ 3 (3)  
Restricted stock grants issued, Shares   350    
Restricted stock grants forfeiture   $ (5) 5  
Restricted stock grants forfeitures, shares   (500)    
Stock-based compensation 72,218   72,218  
Net income 664,216     664,216
Dividends (822,009)     (822,009)
Ending Balance at Jun. 30, 2025 47,189,264 $ 113,382 49,732,485 (2,656,603)
Ending Balance, shares at Jun. 30, 2025   11,338,241    
Restricted stock grants issued   $ 3 (3)  
Restricted stock grants issued, Shares   292    
Restricted stock grants forfeiture   $ (8) 8  
Restricted stock grants forfeitures, shares   (813)    
Stock-based compensation 70,948   70,948  
Net income 496,259     496,259
Dividends (821,985)     (821,985)
Ending Balance at Sep. 30, 2025 $ 46,934,486 $ 113,377 $ 49,803,438 $ (2,982,329)
Ending Balance, shares at Sep. 30, 2025 11,337,720 11,337,720